EMA Authorised: Viramune (nevirapine) — Boehringer Ingelheim International GmbH

View source ↗

Summary

The European Medicines Agency authorised Viramune (nevirapine) by Boehringer Ingelheim International GmbH for the treatment of HIV infections, with the decision…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Boehringer Ingelheim International GmbH. Decision date: 07/04/2026